Amount Raised
$60 Million
Round Type
Funding Round
Description
Ncardia, a leader in developing stem cell-based solutions for drug discovery and cell therapy, announced that it has secured more than $60 million in capital through a strategic partnership with Kiniciti, a U.S.-based investment platform focused on strengthening the cell and gene therapy ecosystem worldwide. Kiniciti is backed by Welsh, Carson, Anderson & Stowe (WCAS), a leading private equity firm investing in healthcare and technology, and Biospring Partners. The transaction gives Kiniciti a control stake in Ncardia to support growth and enhance capabilities spanning discovery to clinical programs to commercial production.
Who else raised in Science And Engineering and Biotechnology around the same time
Companies in the same sectors as Ncardia that raised within 45 days of this round, from Fundz verified event records.
- Trait Biosciences Inc. raised an undisclosed amount (Series A) on December 30, 2021.
- TandemAI raised $25M (Seed) on December 22, 2021.
- Appili Therapeutics Inc. raised an undisclosed amount (Funding Round) on December 22, 2021.
- 20n Bio raised $3.3M (Seed) on December 17, 2021.
- Specific Biologics raised an undisclosed amount (Seed) on December 16, 2021.
- Mythic Therapeutics raised an undisclosed amount (Series B) on December 15, 2021.
Who to call at Ncardia, and when
A new round usually means Ncardia is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Ncardia raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Ncardia, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Ncardia. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Ncardia raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Ncardia raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.